SOMIT
Leveraging a novel platform technology to develop a first-in-class immunotherapy for Celiac Disease
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0SOMIT project word cloud
Explore the words cloud of the SOMIT project. It provides you a very rough idea of what is the project "SOMIT" about.
Project "SOMIT" data sheet
The following table provides information about the project.
| Coordinator |
ALLERO THERAPEUTICS
Organization address contact info |
| Coordinator Country | Belgium [BE] |
| Project website | http://www.allerotherapeutics.com |
| Total cost | 71˙429 € |
| EC max contribution | 50˙000 € (70%) |
| Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
| Code Call | H2020-SMEInst-2018-2020-1 |
| Funding Scheme | SME-1 |
| Starting year | 2018 |
| Duration (year-month-day) | from 2018-09-01 to 2019-02-28 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | ALLERO THERAPEUTICS | BE (GENT) | coordinator | 50˙000.00 |
Map
Project objective
Celiac Disease is a debilitating autoimmune disorder that is caused by intolerance to gluten. Although it is the most common genetically-based food intolerance in the world, there are currently no therapeutics available to treat patients. In this project, Allero Therapeutics will collaborate with two leading research institutes (Leiden University Medical Center from the Netherlands and the Veterinary Research Institute from the Czech Republic) to develop a first-in-class therapeutic against Celiac Disease. Specifically, this novel therapeutic consists of an antigen-specific immunotherapy combined with tolerizing agents, which will be delivered to the oromucosa via a proprietary sublingual mouth patch. This project consists of a 6-month multi-disciplinary feasibility study that will:
(1) experimentally demonstrate in vitro and ex vivo Proof of Principle for the novel therapeutic; (2) research all required (pre)clinical development to build a detailed roadmap for navigating the regulatory landscape; (3) strengthen and expand the current IP position; and (4) consolidate all current and future findings into an investor-ready Business Plan.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SOMIT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "SOMIT" are provided by the European Opendata Portal: CORDIS opendata.